164 related articles for article (PubMed ID: 23203906)
21. T-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development.
Ewing MM; Karper JC; Abdul S; de Jong RC; Peters HA; de Vries MR; Redeker A; Kuiper J; Toes RE; Arens R; Jukema JW; Quax PH
Int J Cardiol; 2013 Oct; 168(3):1965-74. PubMed ID: 23351788
[TBL] [Abstract][Full Text] [Related]
22. Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists.
Scheinfeld N
J Dermatolog Treat; 2006; 17(4):229-34. PubMed ID: 16971318
[TBL] [Abstract][Full Text] [Related]
23. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
Bossowski A; Stasiak-Barmuta A; Urban M
Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
[TBL] [Abstract][Full Text] [Related]
24. How does abatacept really work in rheumatoid arthritis?
Bonelli M; Scheinecker C
Curr Opin Rheumatol; 2018 May; 30(3):295-300. PubMed ID: 29401118
[TBL] [Abstract][Full Text] [Related]
25. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.
Perrin PJ; Scott D; Quigley L; Albert PS; Feder O; Gray GS; Abe R; June CH; Racke MK
J Immunol; 1995 Feb; 154(3):1481-90. PubMed ID: 7529805
[TBL] [Abstract][Full Text] [Related]
26. The role of CD28-B7 costimulation in allergen-induced cytokine release by bronchial mucosa from patients with moderately severe asthma.
Lordan JL; Davies DE; Wilson SJ; Dent G; Corkhill A; Jaffar Z; Roberts K; Djukanović R; Holgate ST
J Allergy Clin Immunol; 2001 Dec; 108(6):976-81. PubMed ID: 11742276
[TBL] [Abstract][Full Text] [Related]
27. Altered expression of costimulatory molecules in Behçet's disease according to clinical activity.
Sim JH; Park MJ; Park S; Lee ES
Br J Dermatol; 2011 Jun; 164(6):1285-91. PubMed ID: 21574973
[TBL] [Abstract][Full Text] [Related]
28. Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis.
Massarotti EM
Clin Ther; 2008 Mar; 30(3):429-42. PubMed ID: 18405783
[TBL] [Abstract][Full Text] [Related]
29. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells.
Verwilghen J; Lovis R; De Boer M; Linsley PS; Haines GK; Koch AE; Pope RM
J Immunol; 1994 Aug; 153(3):1378-85. PubMed ID: 7517975
[TBL] [Abstract][Full Text] [Related]
30. Suppressive influences of methotrexate on the generation of CD14(+) monocyte-lineage cells from bone marrow of patients with rheumatoid arthritis.
Hirohata S; Yanagida T; Hashimoto H; Tomita T; Ochi T
Clin Immunol; 1999 Apr; 91(1):84-9. PubMed ID: 10219258
[TBL] [Abstract][Full Text] [Related]
31. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
Sherrer Y
Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases.
Matsui T; Kurokawa M; Kobata T; Oki S; Azuma M; Tohma S; Inoue T; Yamamoto K; Nishioka K; Kato T
J Immunol; 1999 Apr; 162(7):4328-35. PubMed ID: 10201965
[TBL] [Abstract][Full Text] [Related]
33. Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D
Transplantation; 2008 Jun; 85(12):1826-32. PubMed ID: 18580477
[TBL] [Abstract][Full Text] [Related]
34. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
35. Costimulation and its role in organ transplantation.
Bluestone JA
Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
[TBL] [Abstract][Full Text] [Related]
36. Synovium infiltrating T cells induce excessive synovial cell function through CD28/B7 pathway in patients with rheumatoid arthritis.
Shimoyama Y; Nagafuchi H; Suzuki N; Ochi T; Sakane T
J Rheumatol; 1999 Oct; 26(10):2094-101. PubMed ID: 10529123
[TBL] [Abstract][Full Text] [Related]
37. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
38. Recognition of cell surface GD3 by monoclonal antibody anti-6C2 in rheumatoid arthritis synovial fluid: expression on human T cells with transendothelial migratory activity.
Homma T; Hosono O; Iwata S; Ando S; Sasaki K; Nishi T; Kawasaki H; Tanaka H; Morimoto C
Arthritis Rheum; 2001 Feb; 44(2):296-306. PubMed ID: 11229459
[TBL] [Abstract][Full Text] [Related]
39. Specific overexpression of tumour necrosis factor-α-induced protein (TNFAIP)9 in CD14(+) CD16(-) monocytes in patients with rheumatoid arthritis: comparative analysis with TNFAIP3.
Takai C; Matsumoto I; Inoue A; Umeda N; Tanaka Y; Kurashima Y; Wada Y; Narita I; Sumida T
Clin Exp Immunol; 2015 Jun; 180(3):458-66. PubMed ID: 25683200
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment.
Wijngaarden S; van Roon JA; van de Winkel JG; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2005 Jun; 44(6):729-34. PubMed ID: 15757966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
